Literature DB >> 18198933

Modelling methods for pharmacoeconomics and health technology assessment: an overview and guide.

James E Stahl1.   

Abstract

This paper provides an overview of, and guidance as to when, why and how to choose and use, different simulation modelling methods as applied to healthcare. What simulation is and why it is necessary in addressing healthcare problems are discussed. In addition, key criteria for choosing an appropriate method (project type, population resolution, interactivity, treatment of time and space, resource constraints, autonomy and how knowledge is embedded) are covered. Key concepts for each method, moving from the simplest to most complex methods, are reviewed in some detail.

Mesh:

Year:  2008        PMID: 18198933     DOI: 10.2165/00019053-200826020-00004

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  40 in total

1.  Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective.

Authors:  W J Edmunds; G F Medley; D J Nokes
Journal:  Stat Med       Date:  1999-12-15       Impact factor: 2.373

2.  Social networks and collateral health effects.

Authors:  Nicholas A Christakis
Journal:  BMJ       Date:  2004-07-24

3.  Modelling in the economic evaluation of health care: selecting the appropriate approach.

Authors:  Pelham Barton; Stirling Bryan; Suzanne Robinson
Journal:  J Health Serv Res Policy       Date:  2004-04

4.  Vicious circles in inflammatory bowel disease.

Authors:  Amnon Sonnenberg; Judith F Collins
Journal:  Inflamm Bowel Dis       Date:  2006-10       Impact factor: 5.325

5.  The Monte Carlo method.

Authors:  N METROPOLIS; S ULAM
Journal:  J Am Stat Assoc       Date:  1949-09       Impact factor: 5.033

6.  Ethical complexities of conducting research in developing countries.

Authors:  H Varmus; D Satcher
Journal:  N Engl J Med       Date:  1997-10-02       Impact factor: 91.245

7.  Reorganizing patient care and workflow in the operating room: a cost-effectiveness study.

Authors:  James E Stahl; Warren S Sandberg; Bethany Daily; Richard Wiklund; Marie T Egan; Julian M Goldman; Keith B Isaacson; Scott Gazelle; David W Rattner
Journal:  Surgery       Date:  2006-06       Impact factor: 3.982

8.  Simulation applied to health services: opportunities for applying the system dynamics approach.

Authors:  K Taylor; D Lane
Journal:  J Health Serv Res Policy       Date:  1998-10

9.  Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.

Authors:  Ruanne V Barnabas; Päivi Laukkanen; Pentti Koskela; Osmo Kontula; Matti Lehtinen; Geoff P Garnett
Journal:  PLoS Med       Date:  2006-04-04       Impact factor: 11.069

10.  Systems modeling in support of evidence-based disaster planning for rural areas.

Authors:  Mama Hoard; Jack Homer; William Manley; Paul Furbee; Arshadul Haque; James Helmkamp
Journal:  Int J Hyg Environ Health       Date:  2005       Impact factor: 5.840

View more
  43 in total

1.  Population- versus cohort-based modelling approaches.

Authors:  Olivier Ethgen; Baudouin Standaert
Journal:  Pharmacoeconomics       Date:  2012-03       Impact factor: 4.981

2.  Research priorities in pharmacokinetics.

Authors:  Geoffrey T Tucker
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

3.  Cost-effectiveness modeling of abatacept versus other biologic agents in DMARDS and anti-TNF inadequate responders for the management of moderate to severe rheumatoid arthritis.

Authors:  Anthony Russell; Ariel Beresniak; Louis Bessette; Boulos Haraoui; Proton Rahman; Carter Thorne; Ross Maclean; Danielle Dupont
Journal:  Clin Rheumatol       Date:  2008-12-17       Impact factor: 2.980

4.  Comparison of Markov model and discrete-event simulation techniques for HIV.

Authors:  Kit N Simpson; Alvin Strassburger; Walter J Jones; Birgitta Dietz; Rukmini Rajagopalan
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

5.  Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model.

Authors:  G Feljandro P Ramos; Antoinette D I van Asselt; Sandra Kuiper; Johan L Severens; Tanja Maas; Edward Dompeling; J André Knottnerus; Onno C P van Schayck
Journal:  Eur J Health Econ       Date:  2013-10-06

6.  Comparing three software tools for implementing markov models for health economic evaluations.

Authors:  Petra Menn; Rolf Holle
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 7.  [Modeling in value-based medicine].

Authors:  A S Neubauer; C Hirneiss; A Kampik
Journal:  Ophthalmologe       Date:  2010-03       Impact factor: 1.059

8.  Economic evaluations with agent-based modelling: an introduction.

Authors:  Jagpreet Chhatwal; Tianhua He
Journal:  Pharmacoeconomics       Date:  2015-05       Impact factor: 4.981

Review 9.  Overview and Use of Tools for Selecting Modelling Techniques in Health Economic Studies.

Authors:  Huajie Jin; Stewart Robinson; Wenru Shang; Evanthia Achilla; David Aceituno; Sarah Byford
Journal:  Pharmacoeconomics       Date:  2021-05-20       Impact factor: 4.981

10.  Validation of a DICE Simulation Against a Discrete Event Simulation Implemented Entirely in Code.

Authors:  Jörgen Möller; Sarah Davis; Matt Stevenson; J Jaime Caro
Journal:  Pharmacoeconomics       Date:  2017-10       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.